Maliheh Davari: Exploring CRISPR Activation for Hemophilia at ISTH 2026
Maliheh Davari, Postdoctoral Fellow at Queen’s University, shared a post on LinkedIn:
“I am thrilled to announce that I had the opportunity to present my study, ‘Targeted CRISPRa-Mediated Enhancement of Inverted F8 Exon 1–22 Fragment Expression in Hemophilic Canine Endothelial Cells’, at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris.
It was a great privilege to share our work with researchers and clinicians from around the world and to engage in valuable scientific discussions.
I would like to express my sincere gratitude to my supervisor, Dr. David Lillicrap, for his invaluable mentorship, continuous guidance, and unwavering support throughout this project.
Presenting at ISTH has been an enriching experience, and I look forward to continuing this research and contributing to advances in the field of thrombosis and hemostasis.”
Stay updated with Hemostasis Today.
-
Jul 27, 2026, 08:10Colleen Kelly: Bridging the Access Gap in Gene Therapy for Sickle Cell Disease
-
Jul 27, 2026, 07:59James P. Crowley: A New Era in Cardiovascular Risk Prevention
-
Jul 27, 2026, 07:42Shayan Mohammadmoradi: Leading Membership Growth and Scientific Engagement in ATVB
-
Jul 27, 2026, 06:45Maha Othman: The Value of Trusted Scientific Reporting at ISTH 2026
-
Jul 27, 2026, 04:50A Significant Step Forward for People with Bleeding Disorders in the Dominican Republic – WFH
-
Jul 27, 2026, 04:11Mohamed F Doheim: Clarifying the Role of Late IV Thrombolysis in the Era of Endovascular Therapy
-
Jul 27, 2026, 03:50Françoise Dignat-George: The Rising Impact of Extracellular Vesicles Spotlighted at ISTH 2026
-
Jul 27, 2026, 03:42Koson Tony Sriamporn: A Milestone for Inclusive Blood Donor Eligibility
-
Jul 27, 2026, 03:34Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026